Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

2011/01/B/NZ4/04829

Keywords:

acute lymphoblastic leukemia HIF-1 alpha ERK DNA damage drug resistance mechanisms targeted therapy

Descriptors:

  • NZ4_11: Metabolism
  • NZ5_3: Pathogenesis of human diseases
  • NZ5_7: Human disease treatment

Panel:

NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution :

Instytut Hematologii i Transfuzjologii

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Przemysław Juszczyński 

Number of co-investigators in the project: 4

Call: OPUS 1 - announced on 2011-03-15

Amount awarded: 488 000 PLN

Project start date (Y-m-d): 2011-12-16

Project end date (Y-m-d): 2015-06-15

Project duration:: 42 months (the same as in the proposal)

Project status: Project settled

Equipment purchased [PL]

  1. Zestaw do elektroferezy Comet Assay (15 000 PLN)
  2. Automatyczny licznik i analizator komórkowy Countess (28 000 PLN)
  3. Komora laminarna.

Information in the final report

  • Publication in academic press/journals (1)
  • Articles in post-conference publications (1)
  1. MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy
    Authors:
    Anna Polak, Przemyslaw Kiliszek, Tomasz Sewastianik, Maciej Szydlowski, Ewa Jablonska, Emilia Bialopiotrowicz, Patryk Gorniak, Sergiusz Markowicz, Eliza Nowak, Monika A. Grygorowicz, Dominika Nowis, Jakub Golab, Sebastian Giebel, Ewa Lech-Maranda, Krzysztof Warzocha, Przemyslaw Juszczynski
    Academic press:
    PLOS One (rok: 2016, tom: 11, strony: n/a), Wydawca: PLOS
    Status:
    Published
    DOI:
    10.1371/journal.pone.0155893 - link to the publication
  1. MEK1 inhibitor selumetinib sensitizes B-cell acute lymphoblastic leukemia (B-ALL) cells to dexamethasone by modulating autophagy
    Authors:
    Polak A, Kiliszek P, Sewastianik T., Szydlowski M., Jablonska E., Prusisz W., Bialopiotrowicz E., Markowicz S., Nowak E., Grygorowicz M., Nowis D., Bojarczuk K., Golab J., Juszczynski P
    Conference:
    19th Congress of the European Hematology Association, 12-15 June, 2014, Milan, Italy (rok: 2014, ), Wydawca: European Hematology Association
    Data:
    konferencja 12-15 June, 2014, Milan, Italy
    Status:
    Published